1. Home
  2. ATS vs ZLAB Comparison

ATS vs ZLAB Comparison

Compare ATS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$19.45

Market Cap

2.6B

Sector

N/A

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.47

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
ZLAB
Founded
1978
2013
Country
Canada
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
ATS
ZLAB
Price
$19.45
$25.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$35.00
$49.60
AVG Volume (30 Days)
216.1K
1.2M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$17.99
$9.75
Revenue Next Year
$4.52
$26.03
P/E Ratio
$222.92
N/A
Revenue Growth
N/A
15.33
52 Week Low
$18.41
$15.96
52 Week High
$35.82
$34.72

Technical Indicators

Market Signals
Indicator
ATS
ZLAB
Relative Strength Index (RSI) 37.27 55.00
Support Level $19.14 $24.81
Resistance Level $20.11 $27.08
Average True Range (ATR) 0.50 0.76
MACD 0.29 -0.29
Stochastic Oscillator 53.24 22.12

Price Performance

Historical Comparison
ATS
ZLAB

About ATS ATS Corporation

ATS Corp is engaged in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers. The company focuses in five key markets: life sciences, food & beverage, transportation, consumer products and energy. The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements practices on a world-wide basis. The company has presence in Canada, United States, Germany, Italy, Other Europe, and Other.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: